Short Interest in Global X HealthTech ETF (NASDAQ:HEAL) Decreases By 62.7%

Global X HealthTech ETF (NASDAQ:HEAL) saw a significant drop in short interest in the month of August. As of August 31st, there was short interest totaling 5,796 shares, a drop of 62.7% from the August 15th total of 15,534 shares. Currently, 0.5% of the shares of the stock are sold short. Based on an average trading volume of 14,071 shares, the days-to-cover ratio is currently 0.4 days.

Hedge Funds Weigh In On Global X HealthTech ETF

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HEAL. Royal Bank of Canada increased its holdings in shares of Global X HealthTech ETF by 39.4% during the first quarter. Royal Bank of Canada now owns 2,603 shares of the company’s stock worth $62,000 after buying an additional 736 shares in the last quarter. WT Wealth Management grew its position in Global X HealthTech ETF by 14.7% during the 1st quarter. WT Wealth Management now owns 101,116 shares of the company’s stock worth $2,409,000 after acquiring an additional 12,945 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its holdings in Global X HealthTech ETF by 26,522.2% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,396 shares of the company’s stock valued at $70,000 after purchasing an additional 2,387 shares in the last quarter.

Global X HealthTech ETF Stock Performance

Shares of NASDAQ:HEAL traded down $0.13 on Tuesday, hitting $29.02. The stock had a trading volume of 22,761 shares, compared to its average volume of 10,567. The firm’s 50 day moving average price is $28.53 and its 200-day moving average price is $26.56. Global X HealthTech ETF has a twelve month low of $23.00 and a twelve month high of $33.59. The company has a market capitalization of $58.01 million, a price-to-earnings ratio of 42.80 and a beta of 1.11.

Global X HealthTech ETF Company Profile

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.